-
Most Recent
Cannabis Stocks
Cannabis is a psychoactive drug that is a part of the Cannabacaee plant family. In the past few years, acceptance of the drug has risen dramatically. Industry leaders, like Canopy Growth and Curaleaf, are quickly establishing the framework for legal cannabis sales. THC is believed to be the component in cannabis that creates the psychoactive effect, which can be used to treat depression, anxiety, sleeping problems, and a wide range of other issues.
3 Cannabis Stocks That Can Be Massive Wealth Creators by 2030
These are the cannabis stocks to buy as they represent companies with improving fundamentals and accelerated growth outlook.
7 Growth Stocks That Could 7X in the Next 7 Years
Investors consider these growth stocks to buy since they represent companies with good fundamentals and a positive industry outlook.
3 Cannabis Stocks to Sell in August Before They Crash & Burn
Marijuana could be a major industry in the U.S. if it was legalized but these cannabis stocks to sell have other problems to contend with.
Other industries you might be interested in
Recent Cannabis Stocks Articles
Investors Should Use Other Metrics to Evaluate Cronos Group Stock
Some believe that Cronos stock overvalued. But if you consider cash on the balance sheet, CRON stock is more than reasonable.
Even With New CEO, Debt-Laden Rite Aid Stock is Best Avoided for Near Term
RAD stock hasn't benefited when management gave up selling electronic cigarettes while taking on CBD products. That's not the turnaround strategy it needs.
Aurora Cannabis Stock Will Be Boosted by ACB’s Retail Expansion
Aurora’s medical cannabis business is strong and can boost ACB stock over time. Also likely to help Aurora stock is ACB's retail expansion.
My Misgivings About Aurora Cannabis Stock Continue to Grow
A year after legalization, things aren't looking good for ACB stock. I recommend waiting on the sidelines until vaping risks clear up.
Aurora Cannabis Stock Could Climb in the Long-Term
Like all the other marijuana stocks, ACB stock has been beaten up, but Aurora stock may have more potential than its rivals.
The Bubble Has Burst, But Tilray Stock Is More Than a Penny Stock
Tilray stock is hovering near its IPO level. The cannabis bubble has burst, but that doesn't mean TLRY should be treated like a penny stock.
Aurora Cannabis Stock Demonstrates Promising Trading Opportunities
ACB stock's trading range is tight and a move is coming. After a 60% drop, much of the fat has been shed and there are breakout lines just above.
Aurora Stock: Why It’s Worthwhile for Speculators
Like just about every other marijuana stock, ACB stock has been in bear mode. But this is creating an interesting opportunity. Here’s a look at why now might be the time to consider Aurora stock.
Have Patience With Aurora Cannabis Stock
ACB stock is a long-term winner that won't get on its long-term winning path until near-term operational risks pass.
Why the Slide of Tilray Stock May Continue
Tilray stock has been stuck in a multi-quarter decline, and the fundamentals imply that the slide of TLRY stock may not be over.
Hexo Stock Might Rebound in 2020
Although HEXO is facing multiple challenges now, including higher costs, the longer term outlook of Hexo stock is upbeat.
Cronos Stock Will Eventually Rebound, but Not Anytime Soon
Like many other high quality pot stocks, CRON stock will eventually rebound from this sell-off, but not here, and not now.
It’s All About the Weed for Aphria Stock
While Aphria’s growth capacity expansion is big news, a more critical catalyst for Aphria stock could be its medicinal marijuana brand.
Why Canopy Growth Stock Can Rise in the Long-Term
CGC's focus on clinical trials and evidence-based medicinal use is likely to be positive for CGC stock over the long-term.
Is November the Time to Buy Aurora Cannabis Stock?
Unless ACB stock's sales growth translates into profits, there is likely to be little upside potential in the share price.
Holiday Spirits Are High Thanks to Canopy Growth’s Edibles
Cannabis-infused beverages and edibles are now legal in Canada. Canopy Growth has a responsible plan. That’s good for CGC stock.
The Overblown Squarepocalypse Melodrama Won’t Stop Square Stock
Square stock may have incurred some negative press from raising its merchant transaction costs, but the overall picture for the company remains bright.
Hexo Stock Is Far Too Dangerous at This Point
Hexo stock price is cheaper, but hardly cheap enough for a business that appears to be in disarray.
